<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To investigate the behaviour of <z:chebi fb="111" ids="27732">caffeine</z:chebi> (CAF) in patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's Syndrome</z:e> (GS), a combined oral loading test of <z:chebi fb="111" ids="27732">caffeine</z:chebi> and <z:chebi fb="0" ids="16755">chenodeoxycholic acid</z:chebi> was performed in 14 healthy subjects and 71 patients with GS </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="31696">Indocyanine green</z:chebi> (ICG) kinetics was tested in 50 subjects with GS and in <z:hpo ids='HP_0000001'>all</z:hpo> control subjects </plain></SENT>
<SENT sid="2" pm="."><plain>Fasting serum <z:chebi fb="1" ids="3098">bile acids</z:chebi> (SBA) and clearance after <z:chebi fb="0" ids="16755">CDCA</z:chebi> loading were within <z:mpath ids='MPATH_458'>normal</z:mpath> range in <z:mpath ids='MPATH_458'>normal</z:mpath> and GS subjects </plain></SENT>
<SENT sid="3" pm="."><plain>No significant difference in levels either of <z:chebi fb="0" ids="16990">bilirubin</z:chebi> or of SBA was observed in GS cases with <z:mpath ids='MPATH_458'>normal</z:mpath> (52 cases, 488 +/- 63 ml/min) or impaired (19 cases, 338 +/- 30 ml/min) <z:chebi fb="111" ids="27732">caffeine</z:chebi> clearance </plain></SENT>
<SENT sid="4" pm="."><plain>Eleven GS cases showed altered ICG clearance </plain></SENT>
<SENT sid="5" pm="."><plain>No correlation was found between <z:chebi fb="0" ids="16990">bilirubin</z:chebi> and <z:chebi fb="1" ids="3098">bile acids</z:chebi>, CAF or ICG </plain></SENT>
<SENT sid="6" pm="."><plain>Fasting SBA were <z:mpath ids='MPATH_458'>normal</z:mpath> even in cases of CAF or ICG altered kinetics, thus excluding structural damage in <z:hpo ids='HP_0008282'>unconjugated hyperbilirubinemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>CAF altered kinetics in 27% of GS cases may suggest multiple deficits in the hepatocellular metabolism, thus confirming the <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of this syndrome </plain></SENT>
</text></document>